Genetic variants in AKT1 gene were associated with risk and survival of OSCC in Chinese Han Population

Journal of Oral Pathology and Medicine

Volumn 44, Issue 1, 2015, Pages 45-50

  Wang, Yun ^a   Lin, Lin ^a   Xu, Hao ^a,b   Li, Taiwen ^a   Zhou, Yu ^a   Dan, Hongxia ^a   Jiang, Lu ^a   Liao, Ga ^a   Zhou, Min ^a   Li, Longjiang ^a   Zeng, Xin ^a   Li, Jing ^a   Chen, Qianming ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

AKT1; Oral squamous cell carcinoma; Single nucleotide polymorphism; Survival; Susceptibility

Indexed keywords

GENOMIC DNA; AKT1 PROTEIN, HUMAN; CYTOSINE; PROTEIN KINASE B; THYMINE;

ADULT; AKT1 GENE; ALLELE; ARTICLE; CANCER GROWTH; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CHI SQUARE TEST; CHINESE; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; MUTANT; SINGLE NUCLEOTIDE POLYMORPHISM; SOFTWARE; AGED; CHINA; COHORT ANALYSIS; DISEASE COURSE; ETHNIC GROUP; ETHNOLOGY; FOLLOW UP; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; MIDDLE AGED; MOUTH TUMOR; MUTATION; RISK FACTOR; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

AGED; ALLELES; CARCINOMA, SQUAMOUS CELL; CHINA; COHORT STUDIES; CYTOSINE; DISEASE PROGRESSION; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-AKT; RISK FACTORS; SIGNAL TRANSDUCTION; SURVIVAL RATE; THYMINE;

EID: 84920287829     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12211     Document Type: Article

References (36)

1. Johnson NW, Jayasekara P, Amarasinghe AA. Squamous cell carcinoma and precursor lesions of the oral cavity: epidemiology and aetiology. Periodontol 2000 2011; 57: 19-37.
2. Weinberg MA, Estefan DJ. Assessing oral malignancies. Am Fam Physician 2002; 65: 1379-84.
3. Messadi DV. Diagnostic aids for detection of oral precancerous conditions. Int J Oral Sci 2013; 5: 59-65.
4. Stadler ME, Patel MR, Couch ME, Hayes DN. Molecular biology of head and neck cancer: risks and pathways. Hematol Oncol Clin North Am 2008; 22: 1099-124, vii.
5. Vanhaesebroeck B, Waterfield MD. Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res 1999; 253: 239-54.
6. Katso R, Okkenhaug K, Ahmadi K, White S, Timms J, Waterfield MD. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu Rev Cell Dev Biol 2001; 17: 615-75.
7. Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 2006; 7: 606-19.
8. Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet 2004; 36: 131-7.
9. George S, Rochford JJ, Wolfrum C, et al. A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 2004; 304: 1325-8.
10. Altomare DA, Testa JR. Perturbations of the AKT signaling pathway in human cancer. Oncogene 2005; 24: 7455-64.
11. Franke TF. PI3K/Akt: getting it right matters. Oncogene 2008; 27: 6473-88.
12. Li Y, Wang J, Wang F, et al. Tissue microarray analysis reveals the expression and prognostic significance of phosphorylated AktThr308 in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol 2013; 116: 591-7.
13. Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005; 10: 40-68.
14. Goc A, Liu J, Byzova TV, Somanath PR. Akt1 mediates prostate cancer cell microinvasion and chemotaxis to metastatic stimuli via integrin beta(3) affinity modulation. Br J Cancer 2012; 107: 713-23.
15. Liu J, Wei XL, Huang WH, Chen CF, Bai JW, Zhang GJ. Cytoplasmic Skp2 expression is associated with p-Akt1 and predicts poor prognosis in human breast carcinomas. PLoS One 2012; 7: e52675.
16. Sun XF, Sun ZY, Pan B, Li L, Shen W. Alteration in methylation pattern of oncogene Akt1 promoter region in bladder cancer. Mol Biol Rep 2012; 39: 5631-6.
17. Harris SL, Gil G, Robins H, et al. Detection of functional single-nucleotide polymorphisms that affect apoptosis. Proc Natl Acad Sci U S A 2005; 102: 16297-302.
18. Zai CC, Romano-Silva MA, Hwang R, et al. Genetic study of eight AKT1 gene polymorphisms and their interaction with DRD2 gene polymorphisms in tardive dyskinesia. Schizophr Res 2008; 106: 248-52.
19. Schwab SG, Hoefgen B, Hanses C, et al. Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families. Biol Pshychiatry 2005; 58: 446-50.
20. Ide M, Ohnishi T, Muray M, et al. Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia. J Neurochem 2006; 99: 277-87.
21. Kim MJ, Kang HG, Lee SY, et al. AKT1 polymorphisms and survival of early stage non-small cell lung cancer. J Surg Oncol 2012; 105: 167-74.
22. Yarden RI, Friedman E, Metsuyanim S, Olender T, Ben-Asher E, Papa MZ. Single-nucleotide polymorphisms in the p53 pathway genes modify cancer risk in BRCA1 and BRCA2 carriers of Jewish-Ashkenazi descent. Mol Carcinog 2010; 49: 545-55.
23. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005; 15: 97-8.
24. Irie HY, Pearline RV, Grueneberg D, et al. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J Cell Biol 2005; 171: 1023-34.
25. Dillon RL, White DE, Muller WJ. The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer. Oncogene 2007; 26: 1338-45.
26. Wang LE, Ma H, Hale KS, et al. Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes. J Cancer Res Clin Oncol 2012; 138: 377-85.
27. Kwon EM, Salinas CA, Kolb S, et al. Genetic polymorphisms in inflammation pathway genes and prostate cancer risk. Cancer epidemiology, biomarkers & prevention: a publication of the American. Association for. Cancer Res 2011; 20: 923-33.
28. Giovannetti E, Zucali PA, Peters GJ, et al. Association of polymorphisms in AKT1 and EGFR with clinical outcome and toxicity in non-small cell lung cancer patients treated with gefitinib. Mol Cancer Ther 2010; 9: 581-93.
29. Pu X, Hildebrandt MA, Lu C, et al. PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapy. Lung Cancer 2011; 71: 82-8.
30. Harmon BT, Devaney SA, Gordish-Dressman H, et al. Functional characterization of a haplotype in the AKT1 gene associated with glucose homeostasis and metabolic syndrome. Hum Genet 2010; 128: 635-45.
31. Ran C, Westerlund M, Anvret A, et al. Genetic studies of the protein kinase AKT1 in Parkinson's disease. Neurosci Lett 2011; 501: 41-4.
32. Mathur A, Law MH, Megson IL, Shaw DJ, Wei J. Genetic association of the AKT1 gene with schizophrenia in a British population. Psychiatr Genet 2010; 20: 118-22.
33. Karege F, Meary A, Perroud N, et al. Genetic overlap between schizophrenia and bipolar disorder: a study with AKT1 gene variants and clinical phenotypes. Schizophr Res 2012; 135: 8-14.
34. Xu MQ, Xing QH, Zheng YL, et al. Association of AKT1 gene polymorphisms with risk of schizophrenia and with response to antipsychotics in the Chinese population. J Clin Psychiatry 2007; 68: 1358-67.
35. Spears M, Cunningham CA, Taylor KJ, et al. Proximity ligation assays for isoform-specific Akt activation in breast cancer identify activated Akt1 as a driver of progression. J Pathol 2012; 227: 481-9.
36. Hollander MC, Maier CR, Hobbs EA, Ashmore AR, Linnoila RI, Dennis PA. Akt1 deletion prevents lung tumorigenesis by mutant K-ras. Oncogene 2011; 30: 1812-21.